As medical advances have extended life for people with serious illnesses, more demand has been placed on nurses in critical care and end-of-life (EOL) care environments. A recent study published in the Journal of Hospice & Palliative Nursing asked nurses across the United States and the nation’s territories about their experiences providing care for patients at EOL. The qualitative study analyzed the responses from 216 critical care nurses and synthesized the data to come up with 5 distinct themes encompassing ...
Advertisement
Latest News
Among the topics identified by the online survey were cancer biology, treatments, and direct patient care.
Even with a large discrepancy between patients and providers, patients were satisfied with their level of disease knowledge.
Language bias is implicit and can affect the quality of care a patient receives. These 5 strategies help mitigate the bias.
Black and African American cancer survivors tend not to get enough physical activity. What are the causes and solutions?
Cachexia can cause patients to discontinue cancer treatment. Can improving taste and smell ameliorate the weight loss?
Aspiration pneumonia is a severe complication in patients undergoing esophageal cancer treatment. Can it be addressed?
Advertisement
Advertisement
Our Contributors
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Owner of beyond Oncology Education, LLC, and Editor In Chief of Cancer Nursing Today
Kate B. Hubbard, MSN, RN, OCN®, NPD-BCOncology nurse educator with over 15 years of oncology nursing experience
Teresa Hagan Thomas, PhD, RNNurse, writer, and researcher
Expert Interviews
Conference Highlights
A new method of peripheral blood stem cell hematopoietic cell transplantation led to a 1-year chronic GVHD rate of 11%.
Patients who received a triplet regimen as GVHD prophylaxis after HSCT had favorable outcomes.
GVHD was only reported in one patient who received veto cells plus haploidentical T-cell-depleted HSCT.
Belumosudil can impact the pharmacokinetics of tacrolimus and sirolimus, which is important for dosing considerations.
